Evidence map›Paper›PMID 39337588›Full record

ArticleInternational journal of molecular sciences2024

The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in

Denise Vecchie', Julia M Wolter, Jesse Perry, Patricia Jumbo-Lucioni, Maria De Luca

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Denise Vecchie'Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Julia M WolterDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jesse PerryDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0009-0001-8917-8555
Patricia Jumbo-LucioniDepartment of Pharmaceutical, Social and Administrative Sciences, Samford University, Birmingham, AL 35229, USA.ORCID 0000-0003-0266-5498
Maria De LucaDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-6345-7508

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Maitreya J Dunham · 1995 to 2026
$27.1M
Genetic Basis of Lifespan and Healthspan Extension by ACE Inhibition in DrosophilaR01AG073181 · NIA · CLEMSON UNIVERSITY · PI Robert R. H Anholt, MARIA DE LUCA · 2022 to 2026
$2.4M
NIA NIH HHS P30 AG013280NIA NIH HHS R01AG073181NIDDK NIH HHS P30 DK056336
6 · The paper itself

Abstract

Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) may increase metabolic rate by promoting thermogenesis, potentially through enhanced fat oxidation and improved insulin. More research is, however, needed to understand this intricate process. In this study, we used 22 lines from the

Indexed as

Angiotensin-Converting Enzyme InhibitorsDrosophila melanogasterDrosophila ProteinsLisinoprilAnimalsEnergy MetabolismFemaleMalePeptidyl-Dipeptidase AThermogenesisAngiotensin-Converting Enzyme InhibitorsDrosophila ProteinsLisinoprilPeptidyl-Dipeptidase AACE inhibitorsagingbradykininbrainlosartanMalpighian/renal tubulesoxygen consumption rate

Identifiers

PMID39337588
PMCPMC11432024

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.